TY - JOUR T1 - Ocular involvement in children with localized scleroderma: a multicenter study JF - British Journal of Ophthalmology JO - Br J Ophthalmol DO - 10.1136/bjo.2007.116038 AU - Maria Elisabetta Zannin AU - Giorgia Martini AU - Balu H Athreya AU - Ricardo Russo AU - Gloria C Higgins AU - Fabio Vittadello AU - Maria Giannina Alpigiani AU - Mariolina Alessio AU - Mauro Paradisi AU - Patricia Woo AU - Francesco Zulian Y1 - 2007/05/02 UR - http://bjo.bmj.com/content/early/2007/05/02/bjo.2007.116038.abstract N2 - Background: Most of the available documentation in the literature on ocular involvement in Localized Scleroderma (LS) is description of single cases in adult patients. We report the frequency and specific features of ocular involvement in a large cohort of children with Juvenile LS (JLS). Methods: Data from a large, multicenter, multinational study of children with JLS was used, to collect and analyze specific information on ocular involvement. Results: Twenty-four out of 750 patients (3.2%) revealed a significant ocular involvement. Sixteen were female and 8 male. Sixteen patients (66.7%) had scleroderma "En coup de sabre"(ECDS) of the face, 5 (20.8%) had the linear subtype (LS), 2 (8.3%) had generalized morphea (GM) and one (4.2%) had plaque morphea (PM). Of the 24 patients with eye involvement, 10 patients (41.7%) reported adnexa (eyelids and eyelashes) abnormalities, seven (29.2%) anterior segment inflammation (5 anterior uveitis, 2 episcleritis) and 3 central nervous system-related abnormalities. Four patients presented single findings such as paralytic strabismus (1), pseudopapilledema (1), and refractive errors (2). Other extra-cutaneous manifestations, mostly neurological, were detected in a significantly higher number of patients with ocular involvement. Conclusion: Ocular abnormalities are not unusual in patients with JLS, especially in the ECDS subtype. They are frequently associated with other internal organ involvement, particularly the central nervouse system. A careful ophthalmic monitoring is recommended for every patient with JLS, but is mandatory in those with skin lesions on the face and/or concomitant neurological involvement. ER -